447 related articles for article (PubMed ID: 21084465)
1. Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.
Freches D; Romano M; Korf H; Renauld JC; Van Snick J; Uyttenhove C; Huygen K
Clin Vaccine Immunol; 2011 Jan; 18(1):95-104. PubMed ID: 21084465
[TBL] [Abstract][Full Text] [Related]
2. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
[TBL] [Abstract][Full Text] [Related]
3. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon.
Wozniak TM; Saunders BM; Ryan AA; Britton WJ
Infect Immun; 2010 Oct; 78(10):4187-94. PubMed ID: 20679438
[TBL] [Abstract][Full Text] [Related]
6. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.
Jeevan A; Bonilla DL; McMurray DN
Immunology; 2009 Sep; 128(1 Suppl):e296-305. PubMed ID: 19016908
[TBL] [Abstract][Full Text] [Related]
7. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
8. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Kruzel ML; Actor JK
Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
[TBL] [Abstract][Full Text] [Related]
10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
12. The antiasthma effect of neonatal BCG vaccination does not depend on the Th17/Th1 but IL-17/IFN-γ balance in a BALB/c mouse asthma model.
Deng Y; Chen W; Zang N; Li S; Luo Y; Ni K; Wang L; Xie X; Liu W; Yang X; Fu Z; Liu E
J Clin Immunol; 2011 Jun; 31(3):419-29. PubMed ID: 21340706
[TBL] [Abstract][Full Text] [Related]
13. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.
Buddle BM; Shu D; Parlane NA; Subharat S; Heiser A; Hewinson RG; Vordermeier HM; Wedlock DN
Tuberculosis (Edinb); 2016 Jul; 99():120-127. PubMed ID: 27450013
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.
Freidag BL; Melton GB; Collins F; Klinman DM; Cheever A; Stobie L; Suen W; Seder RA
Infect Immun; 2000 May; 68(5):2948-53. PubMed ID: 10768993
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.
Olleros ML; Vesin D; Martinez-Soria E; Allenbach C; Tacchini-Cottier F; Pache JC; Marchal G; Rahman J; Fernández C; Izui S; Garcia I
Immunology; 2007 Nov; 122(3):350-61. PubMed ID: 17623032
[TBL] [Abstract][Full Text] [Related]
17. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
Fulton SA; Martin TD; Redline RW; Henry Boom W
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype.
Rao V; Dhar N; Shakila H; Singh R; Khera A; Jain R; Naseema M; Paramasivan CN; Narayanan PR; Ramanathan VD; Tyagi AK
Scand J Immunol; 2005 May; 61(5):410-7. PubMed ID: 15882432
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.
Derrick SC; Kolibab K; Yang A; Morris SL
Clin Vaccine Immunol; 2014 Oct; 21(10):1443-51. PubMed ID: 25143340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
